Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease aspergillosis
Phenotype C0010674|cystic fibrosis
Sentences 20
PubMedID- 22696329 Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
PubMedID- 25015245 [role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
PubMedID- 25375146 Il-37 markedly reduced nlrp3-dependent neutrophil recruitment and steady state mrna levels of il-1beta production and mitigated lung inflammation and damage in a relevant clinical model, namely aspergillosis in mice with cystic fibrosis.
PubMedID- 22608296 Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens.
PubMedID- 20597074 Risk factors for aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis.
PubMedID- 21067334 Serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art and further challenges.
PubMedID- 23278646 Hla-drb1 and hla-dqb1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
PubMedID- 25431975 Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
PubMedID- 24248318 Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
PubMedID- 24043500 Objectives: to evaluate the efficacy and adverse effects of anti-ige therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
PubMedID- 25705310 Allergic bronchopulmonary aspergillosis in patient with cystic fibrosis - a case report.
PubMedID- 25150265 Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
PubMedID- 26003072 Aim: to establish the prevalence of pulmonary aspergillosis in children with cystic fibrosis under the care of our centre and to investigate the potential predisposing factors to aspergillus infection (ai) and allergic bronchopulmonary aspergillosis (abpa).
PubMedID- 25354514 Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated.
PubMedID- 25010610 Anti ige antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
PubMedID- 24167019 Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
PubMedID- 22448043 Airway colonization with aspergillus causes allergic bronchopulmonary aspergillosis (abpa) in patients with cystic fibrosis or chronic asthma.
PubMedID- 24914809 Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis.
PubMedID- 23278535 Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease.
PubMedID- 26187954 Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated.

Page: 1